An emergency kit used for the treatment of severe hypoglycemia in people with diabetes has been recalled because of a manufacturing defect.

A manufacturing defect has led to the recall of the GlucaGen HypoKit, lot numbers YW60335 and YW60351. (Novo Nordisk Canada)The GlucaGen HypoKit provides an injection of glucagon, a hormone that raises the level of glucose in the blood. It comes with a pre-filled syringe of sterile saline solution and a vial containing the medication. It comes in a bright orange package.

It's intended for use by family members, friends or co-workers in cases where people with diabetes become unconscious due to severe hypoglycemic reactions. The medication is drawn from the vial into the syringe where it is mixed, then injected.

The manufacturing defect is in the pre-filled syringe. In rare cases the syringe may be cracked, allowing the saline to leak out or become contaminated.

Lot numbers for the affected kits are YW60335 and YW60351. The drug identification number is 02333627.

Novo Nordisk Canada, which distributes the kits, is calling on wholesalers, pharmacies and hospitals to stop selling the kits immediately.

Health Canada has not received any reports of illness or injury related to the recalled kits.